Hypertension in pregnancy—what's new in the 2023 ESH Guidelines for the management of arterial hypertension
European Heart Journal - Cardiovascular Pharmacotherapy · 2024
DOI: 10.1093/ehjcvp/pvae012 ↗Kurz gefasst
Editorial in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, 2024. Verfasst von Renata Cífková. Beteiligte Einrichtung: Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech …. Hauptthemen laut MEDLINE: Antihypertensive Agents, Practice Guidelines as Topic, Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic.
- Department of Medicine II, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic.
ORCID-Profile: Renata Cífková
Zitieren
APA
Cífková, R. (2024). Hypertension in pregnancy—what's new in the 2023 ESH Guidelines for the management of arterial hypertension. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae012
Vancouver
Cífková R. Hypertension in pregnancy—what's new in the 2023 ESH Guidelines for the management of arterial hypertension. European Heart Journal - Cardiovascular Pharmacotherapy. 2024. doi:10.1093/ehjcvp/pvae012
BibTeX
@article{Cfkov2024,
author = {Cífková, Renata},
title = {Hypertension in pregnancy—what's new in the 2023 ESH Guidelines for the management of arterial hypertension},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2024},
doi = {10.1093/ehjcvp/pvae012}
}
EUVIMED